232 related articles for article (PubMed ID: 16716781)
21. The genome revolution in vaccine research.
Capecchi B; Serruto D; Adu-Bobie J; Rappuoli R; Pizza M
Curr Issues Mol Biol; 2004 Jan; 6(1):17-27. PubMed ID: 14632256
[TBL] [Abstract][Full Text] [Related]
22. NERVE: new enhanced reverse vaccinology environment.
Vivona S; Bernante F; Filippini F
BMC Biotechnol; 2006 Jul; 6():35. PubMed ID: 16848907
[TBL] [Abstract][Full Text] [Related]
23. Array-based proteomics: high-throughput expression and purification of IMAGE consortium cDNA clones.
Albala JS; Humphery-Smith I
Curr Opin Mol Ther; 1999 Dec; 1(6):680-4. PubMed ID: 19629864
[TBL] [Abstract][Full Text] [Related]
24. Proteomic technology in the design of new effective antibacterial vaccines.
Jagusztyn-Krynicka EK; Dadlez M; Grabowska A; Roszczenko P
Expert Rev Proteomics; 2009 Jun; 6(3):315-30. PubMed ID: 19489702
[TBL] [Abstract][Full Text] [Related]
25. Technology Insight: querying the genome with microarrays--progress and hope for neurological disease.
Coppola G; Geschwind DH
Nat Clin Pract Neurol; 2006 Mar; 2(3):147-58. PubMed ID: 16932541
[TBL] [Abstract][Full Text] [Related]
26. Studies on naturally occurring infectious bursal disease viruses suggest that a single amino acid substitution at position 253 in VP2 increases pathogenicity.
Jackwood DJ; Sreedevi B; LeFever LJ; Sommer-Wagner SE
Virology; 2008 Jul; 377(1):110-6. PubMed ID: 18502466
[TBL] [Abstract][Full Text] [Related]
27. A post-genomic perspective.
Young DB
Nat Med; 2001 Jan; 7(1):11-3. PubMed ID: 11135599
[TBL] [Abstract][Full Text] [Related]
28. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
[TBL] [Abstract][Full Text] [Related]
29. Potency assays for therapeutic live whole cell cancer vaccines.
Petricciani J; Egan W; Vicari G; Furesz J; Schild G
Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomics in the preclinical development of vaccines: evaluation of efficacy and systemic toxicity in the mouse using array technology.
Regnström KJ
Methods Mol Biol; 2008; 448():447-67. PubMed ID: 18370242
[TBL] [Abstract][Full Text] [Related]
31. Genetic diversity among major endemic strains of Leptospira interrogans in China.
He P; Sheng YY; Shi YZ; Jiang XG; Qin JH; Zhang ZM; Zhao GP; Guo XK
BMC Genomics; 2007 Jul; 8():204. PubMed ID: 17603913
[TBL] [Abstract][Full Text] [Related]
32. ASAS centennial paper: Lactation biology for the twenty-first century.
Loor JJ; Cohick WS
J Anim Sci; 2009 Feb; 87(2):813-24. PubMed ID: 18820152
[TBL] [Abstract][Full Text] [Related]
33. Genomic microarrays in clinical diagnosis.
Veltman JA
Curr Opin Pediatr; 2006 Dec; 18(6):598-603. PubMed ID: 17099357
[TBL] [Abstract][Full Text] [Related]
34. From proteomics to systems biology of bacterial pathogens: approaches, tools, and applications.
Plikat U; Voshol H; Dangendorf Y; Wiedmann B; Devay P; Müller D; Wirth U; Szustakowski J; Chirn GW; Inverardi B; Puyang X; Brown K; Kamp H; Hoving S; Ruchti A; Brendlen N; Peterson R; Buco J; Oostrum Jv; Peitsch MC
Proteomics; 2007 Mar; 7(6):992-1003. PubMed ID: 17370256
[TBL] [Abstract][Full Text] [Related]
35. Design and testing of 'genome-proxy' microarrays to profile marine microbial communities.
Rich VI; Konstantinidis K; DeLong EF
Environ Microbiol; 2008 Feb; 10(2):506-21. PubMed ID: 18028413
[TBL] [Abstract][Full Text] [Related]
36. From 'omes to biology.
Quackenbush J
Anim Genet; 2006 Aug; 37 Suppl 1():48-56. PubMed ID: 16887002
[TBL] [Abstract][Full Text] [Related]
37. Reverse vaccinology, a genome-based approach to vaccine development.
Rappuoli R
Vaccine; 2001 Mar; 19(17-19):2688-91. PubMed ID: 11257410
[TBL] [Abstract][Full Text] [Related]
38. DNA microarray applications in functional genomics.
Jares P
Ultrastruct Pathol; 2006; 30(3):209-19. PubMed ID: 16825123
[TBL] [Abstract][Full Text] [Related]
39. High-definition genome profiling for genetic marker discovery.
Zhu T; Salmeron J
Trends Plant Sci; 2007 May; 12(5):196-202. PubMed ID: 17416547
[TBL] [Abstract][Full Text] [Related]
40. New ways to identify novel bacterial antigens for vaccine development.
Movahedi AR; Hampson DJ
Vet Microbiol; 2008 Sep; 131(1-2):1-13. PubMed ID: 18372122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
